FORM |
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
(Exact name of registrant as specified in its charter) |
(State or Other Jurisdiction of Incorporation or Organization) | (I.R.S. Employer Identification No.) | ||||||||||
(Address of Principal Executive Offices) | (Zip Code) |
Title of each class | Trading Symbol(s) | Name of each exchange on which registered | ||||||
Large accelerated filer | ☐ | ☒ | |||||||||
Non-accelerated filer | ☐ | Smaller reporting company | |||||||||
Emerging growth company |
Page | ||||||||
Item 1. | ||||||||
Condensed Consolidated Statements of Cash Flows (Unaudited) | ||||||||
Item 2. | ||||||||
Item 3. | ||||||||
Item 4. | ||||||||
Item 1. | ||||||||
Item 1A. | ||||||||
Item 2. | ||||||||
Item 3. | ||||||||
Item 4. | ||||||||
Item 5. | ||||||||
Item 6. | ||||||||
March 31, 2025 | December 31, 2024 | ||||||||||
(Unaudited) | |||||||||||
ASSETS | |||||||||||
Current assets: | |||||||||||
Cash and cash equivalents | $ | $ | |||||||||
Accounts receivable, net of allowance for expected credit losses of $ | |||||||||||
Inventories | |||||||||||
Prepaid expenses and other | |||||||||||
Total current assets | |||||||||||
Property, plant and equipment, net of accumulated depreciation of $ | |||||||||||
Intangible assets, net of accumulated amortization of $ | |||||||||||
Goodwill | |||||||||||
Operating lease right-of-use assets | |||||||||||
Other assets | |||||||||||
Total assets | $ | $ | |||||||||
LIABILITIES AND STOCKHOLDERS’ DEFICIT | |||||||||||
Current liabilities: | |||||||||||
Accounts payable | $ | $ | |||||||||
Accrued expenses and other current liabilities | |||||||||||
2025 Convertible Notes, net | |||||||||||
Total current liabilities | |||||||||||
Long-term liabilities: | |||||||||||
Operating lease liabilities | |||||||||||
Deferred tax liabilities, net | |||||||||||
2029 Senior Secured Notes, net | |||||||||||
Other long-term liabilities | |||||||||||
Total liabilities | |||||||||||
Commitments and contingencies (Note 10.) | |||||||||||
Stockholders’ deficit: | |||||||||||
Preferred stock, par value $ | |||||||||||
Preferred stock, par value $ | |||||||||||
Common stock, par value $ | |||||||||||
Additional paid-in capital | |||||||||||
Accumulated other comprehensive loss | |||||||||||
Accumulated deficit | ( | ( | |||||||||
Total stockholders’ deficit | ( | ( | |||||||||
Total liabilities and stockholders’ deficit | $ | $ |
Three Months Ended March 31, | |||||||||||
2025 | 2024 | ||||||||||
Revenues: | |||||||||||
Mobile solutions | $ | $ | |||||||||
Fixed wireless access solutions | |||||||||||
Product | |||||||||||
Services and other | |||||||||||
Total revenues | |||||||||||
Cost of revenues: | |||||||||||
Product | |||||||||||
Services and other | |||||||||||
Total cost of revenues | |||||||||||
Gross profit | |||||||||||
Operating costs and expenses: | |||||||||||
Research and development | |||||||||||
Sales and marketing | |||||||||||
General and administrative | |||||||||||
Depreciation and amortization | |||||||||||
Impairment of capitalized software | |||||||||||
Total operating costs and expenses | |||||||||||
Operating income (loss) | ( | ( | |||||||||
Other (expense) income: | |||||||||||
Interest expense | ( | ( | |||||||||
Other income (expense), net | ( | ||||||||||
Income (Loss) before income taxes | ( | ( | |||||||||
Income tax provision | |||||||||||
Income (Loss) from continuing operations | ( | ( | |||||||||
Income (Loss) from discontinued operations (net of income tax provision of $ | ( | ||||||||||
Net income (loss) | ( | ( | |||||||||
Preferred stock dividends | ( | ( | |||||||||
Net income (loss) attributable to common stockholders | $ | ( | $ | ( | |||||||
Per share data: | |||||||||||
Net earnings (loss) per share | |||||||||||
Basic and diluted | |||||||||||
Continuing operations | $ | ( | $ | ( | |||||||
Discontinued operations | ( | ||||||||||
Basic and diluted earnings per share* | $ | ( | $ | ( | |||||||
Weighted-average shares used in computation of net earnings (loss) per share | |||||||||||
Basic and diluted | |||||||||||
Other comprehensive income: | |||||||||||
Foreign currency translation adjustment | |||||||||||
Comprehensive loss | $ | ( | $ | ( |
Preferred Stock | Common Stock | Additional Paid-in Capital (*) | Accumulated Deficit | Accumulated Other Comprehensive (Loss) Income | Total Stockholders’ Deficit | ||||||||||||||||||||||||||||||||||||||||||
Shares | Amount | Shares (*) | Amount (*) | ||||||||||||||||||||||||||||||||||||||||||||
Balance, December 31, 2023 | $ | $ | $ | $ | ( | $ | ( | $ | ( | ||||||||||||||||||||||||||||||||||||||
Net income (loss) | — | — | — | — | — | ( | — | ( | |||||||||||||||||||||||||||||||||||||||
Foreign currency translation adjustment | — | — | — | — | — | — | |||||||||||||||||||||||||||||||||||||||||
Exercises of stock options, vesting of restricted stock units and stock issued under employee stock purchase plan, net of taxes withheld | — | — | — | ( | — | — | ( | ||||||||||||||||||||||||||||||||||||||||
Share-based compensation | — | — | — | — | — | — | |||||||||||||||||||||||||||||||||||||||||
Preferred stock dividends | — | — | — | — | ( | — | |||||||||||||||||||||||||||||||||||||||||
Balance, March 31, 2024 | $ | $ | $ | $ | ( | $ | ( | $ | ( | ||||||||||||||||||||||||||||||||||||||
Balance, December 31, 2024 | $ | $ | $ | $ | ( | $ | $ | ( | |||||||||||||||||||||||||||||||||||||||
Net income (loss) | — | — | — | — | — | ( | — | ( | |||||||||||||||||||||||||||||||||||||||
Foreign currency translation adjustment | — | — | — | — | — | — | |||||||||||||||||||||||||||||||||||||||||
Exercises of stock options, vesting of restricted stock units and stock issued under employee stock purchase plan, net of taxes withheld | — | — | — | ( | — | — | ( | ||||||||||||||||||||||||||||||||||||||||
Share-based compensation | — | — | — | — | — | — | |||||||||||||||||||||||||||||||||||||||||
Preferred stock dividends | — | — | — | — | ( | — | |||||||||||||||||||||||||||||||||||||||||
Balance, March 31, 2025 | $ | $ | $ | $ | ( | $ | $ | ( |
Three Months Ended March 31, | |||||||||||
2025 | 2024 | ||||||||||
Cash flows from operating activities: | |||||||||||
Net income (loss) | $ | ( | $ | ( | |||||||
Adjustments to reconcile net loss to net cash used in (provided by) operating activities: | |||||||||||
(Income) Loss from discontinued operations, net of tax | ( | ||||||||||
Depreciation and amortization | |||||||||||
Provision for expected credit losses | ( | ||||||||||
Impairment of capitalized software | |||||||||||
Provision for excess and obsolete inventory | |||||||||||
Share-based compensation expense | |||||||||||
Amortization of debt discount and debt issuance costs | ( | ||||||||||
Deferred income taxes | |||||||||||
Non-cash operating lease expense | |||||||||||
Changes in assets and liabilities: | |||||||||||
Accounts receivable | |||||||||||
Inventories | ( | ||||||||||
Prepaid expenses and other assets | ( | ||||||||||
Accounts payable | ( | ( | |||||||||
Accrued expenses and other liabilities | ( | ||||||||||
Operating lease liabilities | ( | ( | |||||||||
Operating cash flows from continuing operations | ( | ||||||||||
Operating cash flows from discontinued operations | |||||||||||
Net cash used in (provided by) operating activities | ( | ||||||||||
Cash flows from investing activities: | |||||||||||
Purchases of property, plant and equipment | ( | ||||||||||
Additions to capitalized software development costs and purchases of intangible assets | ( | ( | |||||||||
Investing cash flows from continuing operations | ( | ( | |||||||||
Investing cash flows from discontinued operations | |||||||||||
Net cash used in investing activities | ( | ( | |||||||||
Cash flows from financing activities: | |||||||||||
Net borrowings on revolving credit facility | |||||||||||
Proceeds from stock option exercises and employee stock purchase plan, net of taxes | |||||||||||
Financing cash flows from continuing operations | |||||||||||
Financing cash flows from discontinued operations | |||||||||||
Net cash provided by financing activities | |||||||||||
Effect of exchange rates on cash | ( | ||||||||||
Net decrease (increase) in cash and cash equivalents | ( | ||||||||||
Cash and cash equivalents, beginning of period | |||||||||||
Cash and cash equivalents, end of period | $ | $ | |||||||||
Supplemental disclosures of cash flow information: | |||||||||||
Cash paid during the year for: | |||||||||||
Interest | $ | $ | |||||||||
Income taxes | $ | $ | |||||||||
Supplemental disclosures of non-cash investing and financing activities: | |||||||||||
Capital expenditures financed through accounts payable or accrued liabilities | $ | $ | |||||||||
Three Months Ended March 31, | |||||||||||
2025 | 2024 | ||||||||||
Services and other revenues | $ | $ | |||||||||
Services and other cost of revenues | |||||||||||
Gross profit from discontinued operations | |||||||||||
Operating costs and expenses: | |||||||||||
Research and development | |||||||||||
Sales and marketing | |||||||||||
General and administrative | |||||||||||
Depreciation and amortization | |||||||||||
Total operating costs and expenses | |||||||||||
Operating income from discontinued operations | |||||||||||
Other (expense) income: | |||||||||||
Interest income, net | |||||||||||
Other income (expense), net | |||||||||||
Income from discontinued operations before income taxes | |||||||||||
Income tax provision | |||||||||||
Income (loss) from discontinued operations, net of tax | $ | ( | $ |
March 31, 2025 | December 31, 2024 | ||||||||||
Finished goods | $ | $ | |||||||||
Raw materials and components | |||||||||||
Total inventories | $ | $ |
March 31, 2025 | December 31, 2024 | ||||||||||
Rebate receivables | $ | $ | |||||||||
Software licenses | |||||||||||
Other | |||||||||||
Total prepaid expenses and other | $ | $ |
March 31, 2025 | December 31, 2024 | ||||||||||
Royalties | $ | $ | |||||||||
Payroll and related expenses | |||||||||||
Accrued interest | |||||||||||
Deferred revenue | |||||||||||
Operating lease liabilities | |||||||||||
Accrued contract manufacturing liabilities | |||||||||||
Other | |||||||||||
Total accrued expenses and other current liabilities | $ | $ |
March 31, 2025 | December 31, 2024 | ||||||||||
Long-term deferred revenue | $ | $ | |||||||||
Other | |||||||||||
Total other long-term liabilities | $ | $ |
March 31, 2025 | |||||||||||||||||||||||
Total | Level 1 | Level 2 | Level 3 | ||||||||||||||||||||
Assets: | |||||||||||||||||||||||
Cash equivalents: | |||||||||||||||||||||||
Money market funds | |||||||||||||||||||||||
Total cash equivalents | |||||||||||||||||||||||
March 31, 2025 | December 31, 2024 | ||||||||||
Principal gross amount | $ | $ | |||||||||
Add: unamortized debt premium | |||||||||||
Less: unamortized issuance costs | ( | ( | |||||||||
Net carrying amount | $ | $ |
March 31, 2025 | December 31, 2024 | ||||||||||
Principal | $ | $ | |||||||||
Add: fair value of embedded derivative | $ | ||||||||||
Less: unamortized debt discount | ( | $ | ( | ||||||||
Less: unamortized issuance costs | ( | $ | ( | ||||||||
Net carrying amount | $ | $ |
Three Months Ended March 31, | |||||||||||
2025 | 2024 | ||||||||||
2029 Senior Secured Notes | |||||||||||
Contractual interest expense | $ | $ | |||||||||
Amortization of debt issuance costs | |||||||||||
Amortization of debt discount/premium | ( | ||||||||||
Total interest expense | $ | $ | |||||||||
Related party interest expense | $ | $ | |||||||||
2025 Convertible Notes | |||||||||||
Contractual interest expense | $ | $ | |||||||||
Amortization of debt issuance costs | |||||||||||
Amortization of debt discount/premium | |||||||||||
Total interest expense | $ | $ | |||||||||
Related party interest expense | $ | $ | |||||||||
Credit Facility | |||||||||||
Contractual interest expense | $ | $ | |||||||||
Accretion of exit fee | |||||||||||
Amortization of debt issuance costs | |||||||||||
Total interest expense | $ | $ | |||||||||
Other interest expense | $ | $ | |||||||||
Consolidated interest expense | $ | $ |
Three Months Ended March 31, | |||||||||||
2025 | 2024 | ||||||||||
Cost of revenues | $ | $ | |||||||||
Research and development | |||||||||||
Sales and marketing | |||||||||||
General and administrative | |||||||||||
Income from discontinued operations, net of tax | |||||||||||
Total | $ | $ |
Outstanding — December 31, 2024 | |||||
Granted | |||||
Exercised | ( | ||||
Canceled | ( | ||||
Outstanding — March 31, 2025 | |||||
Exercisable — March 31, 2025 |
January 6, 2025 | |||||
Valuation date stock price | $ | ||||
Simulation term (years) | |||||
Risk-free interest rate | % | ||||
Volatility | % | ||||
Expected dividend yield | % |
Non-vested — December 31, 2024 | |||||
Granted | |||||
Vested | ( | ||||
Forfeited | ( | ||||
Non-vested — March 31, 2025 |
January 6, 2025 | |||||
Valuation date stock price | $ | ||||
Simulation term (years) | |||||
Risk-free interest rate | % | ||||
Volatility | % | ||||
Expected dividend yield | % | ||||
Correlation coefficient |
Income/(Loss) (Numerator) | Shares* (Denominator) | Per-Share Amount** | |||||||||||||||
For the three months ended March 31, 2025 | |||||||||||||||||
Basic and Diluted EPS | |||||||||||||||||
Income (loss) from continuing operations | $ | ( | |||||||||||||||
Less: preferred stock dividends | ( | ||||||||||||||||
Income (loss) from continuing operations attributable to common stockholders | ( | $ | ( | ||||||||||||||
Income from discontinued operations, net of tax | ( | $ | ( | ||||||||||||||
Income (loss) attributable to common stockholders | $ | ( | $ | ( | |||||||||||||
For the three months ended March 31, 2024 | |||||||||||||||||
Basic and Diluted EPS | |||||||||||||||||
Income (loss) from continuing operations | $ | ( | |||||||||||||||
Less: preferred stock dividends | ( | ||||||||||||||||
Income (loss) from continuing operations attributable to common stockholders | ( | $ | ( | ||||||||||||||
Income from discontinued operations, net of tax | $ | ||||||||||||||||
Income (loss) attributable to common stockholders | $ | ( | $ | ( | |||||||||||||
As of March 31, | |||||||||||
2025 | 2024 | ||||||||||
2025 Convertible Notes | |||||||||||
Common stock warrants | |||||||||||
Non-qualified stock options | |||||||||||
Restricted stock units | |||||||||||
Employee stock purchase plan | |||||||||||
Total |
Issuance Date | Number of Shares to Purchase with Warrants | Exercise price | ||||||||||||
June 28, 2024 | $ | |||||||||||||
July 18, 2024 | $ | |||||||||||||
August 2, 2024 | $ | |||||||||||||
October 24, 2024 | $ | |||||||||||||
November 6, 2024 | $ | |||||||||||||
November 6, 2024 | $ | |||||||||||||
November 6, 2024 | $ | |||||||||||||
November 6, 2024 | $ | |||||||||||||
Total |
Three Months Ended March 31, | |||||||||||
2025 | 2024 | ||||||||||
Revenues | $ | $ | |||||||||
Less: | |||||||||||
Adjusted cost of revenues (1) | |||||||||||
Adjusted research and development (2) | |||||||||||
Adjusted sales and marketing (2) | |||||||||||
Adjusted general and administrative (3) | |||||||||||
Adjusted depreciation and amortization (4) | |||||||||||
Capitalizable software development expenditures | |||||||||||
Capitalized software development expenditures | ( | ( | |||||||||
Share-based compensation | |||||||||||
Amortization of purchased intangible assets related to business combinations | |||||||||||
Impairment of capitalized software | |||||||||||
Interest expense | |||||||||||
Other (income) expense, net | ( | ||||||||||
Income tax provision | |||||||||||
Segment net income (loss) | $ | ( | $ | ( | |||||||
Reconciliation of profit or loss | |||||||||||
Income from discontinued operations, net of tax | ( | ||||||||||
Consolidated net income (loss) | $ | ( | $ | ( | |||||||
(1) Excludes any share-based compensation expense. | |||||||||||
(2) Excludes any depreciation and amortization or share-based compensation expense. | |||||||||||
(3) Excludes any depreciation and amortization, share-based compensation expense, right-of-use asset impairments, or debt restructuring costs. | |||||||||||
(4) Excludes amortization of purchased intangible assets. |
Three Months Ended March 31, | |||||||||||
2025 | 2024 | ||||||||||
United States and Canada | $ | $ | |||||||||
Europe (including United Kingdom) | $ | $ | |||||||||
Australia | $ | $ | |||||||||
Total | $ | $ |
Three Months Ended March 31, | Change | ||||||||||||||||||||||
Product Category | 2025 | 2024 | $ | % | |||||||||||||||||||
Mobile solutions | $ | 17,790 | $ | 15,270 | $ | 2,520 | 16.5 | % | |||||||||||||||
Fixed wireless access solutions | 1,903 | 14,182 | (12,279) | (86.6) | |||||||||||||||||||
Product | 19,693 | 29,452 | (9,759) | (33.1) | |||||||||||||||||||
Services and other | 11,980 | 8,053 | 3,927 | 48.8 | |||||||||||||||||||
Total revenues | $ | 31,673 | $ | 37,505 | $ | (5,832) | (15.5) |
Three Months Ended March 31, | Change | ||||||||||||||||||||||
Product Category | 2025 | 2024 | $ | % | |||||||||||||||||||
Product | $ | 15,396 | $ | 22,713 | $ | (7,317) | (32.2) | % | |||||||||||||||
Services and other | 1,294 | 1,548 | (254) | (16.4) | |||||||||||||||||||
Total cost of revenues | $ | 16,690 | $ | 24,261 | $ | (7,571) | (31.2) |
Three Months Ended March 31, | Change | ||||||||||||||||||||||
Operating costs and expenses | 2025 | 2024 | $ | % | |||||||||||||||||||
Research and development | $ | 4,535 | $ | 4,683 | $ | (148) | (3.2) | % | |||||||||||||||
Sales and marketing | 3,934 | 3,839 | 95 | 2.5 | |||||||||||||||||||
General and administrative | 4,490 | 3,955 | 535 | 13.5 | |||||||||||||||||||
Depreciation and amortization | 2,064 | 3,292 | (1,228) | (37.3) | |||||||||||||||||||
Impairment of capitalized software | 384 | 420 | (36) | (8.6) | |||||||||||||||||||
Total | $ | 15,407 | $ | 16,189 | $ | (782) | (4.8) |
Three Months Ended March 31, | Change | ||||||||||||||||||||||
Other (expense) income | 2025 | 2024 | $ | % | |||||||||||||||||||
Interest expense | $ | (1,026) | $ | (2,179) | $ | 1,153 | (52.9) | % | |||||||||||||||
Other income (expense), net | 303 | (375) | 678 | * | |||||||||||||||||||
Total | $ | (723) | $ | (2,554) | $ | 1,831 | (71.7) | % |
Three Months Ended March 31, | |||||||||||
2025 | 2024 | ||||||||||
Operating cash flows from continuing operations | $ | (3,467) | $ | 3,942 | |||||||
Operating cash flows from discontinued operations | — | 1,298 | |||||||||
Net cash used in (provided by) operating activities | (3,467) | 5,240 | |||||||||
Investing cash flows from continuing operations | (1,725) | (577) | |||||||||
Investing cash flows from discontinued operations | 710 | — | |||||||||
Net cash used in investing activities | (1,015) | (577) | |||||||||
Financing cash flows from continuing operations | 42 | 583 | |||||||||
Financing cash flows from discontinued operations | — | — | |||||||||
Net cash provided by financing activities | 42 | 583 | |||||||||
Effect of exchange rates on cash | (7) | 226 | |||||||||
Net decrease (increase) in cash and cash equivalents | (4,447) | 5,472 | |||||||||
Cash and cash equivalents, beginning of period | 39,596 | 2,409 | |||||||||
Cash and cash equivalents, end of period | $ | 35,149 | $ | 7,881 |
Incorporated by Reference to: | |||||||||||||||||
Exhibit No. | Description | Form | Exhibit | Filing Date | |||||||||||||
3.1 | 8-K | 3.1 | 11/9/2016 | ||||||||||||||
3.2* | |||||||||||||||||
3.3 | 8-K | 3.1 | 8/13/2019 | ||||||||||||||
3.4 | 8-K | 3.1 | 3/10/2020 | ||||||||||||||
3.5 | 8-K | 3.1 | 1/23/2024 | ||||||||||||||
10.1** | 8-K | 10.1 | 1/6/2025 | ||||||||||||||
31.1* | |||||||||||||||||
31.2* | |||||||||||||||||
32.1# | |||||||||||||||||
32.2# | |||||||||||||||||
101.INS | Inline XBRL Instance Document - the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document. | ||||||||||||||||
101.SCH | Inline XBRL Taxonomy Extension Schema Document. | ||||||||||||||||
101.CAL | Inline XBRL Taxonomy Extension Calculation Linkbase Document. | ||||||||||||||||
101.DEF | Inline XBRL Taxonomy Extension Definition Linkbase Document. | ||||||||||||||||
101.LAB | Inline XBRL Taxonomy Extension Label Linkbase Document. | ||||||||||||||||
101.PRE | Inline XBRL Taxonomy Extension Presentation Linkbase Document. | ||||||||||||||||
104 | Cover Page Interactive Data File (formatted as inline XBRL and contained in Exhibit 101). | ||||||||||||||||
* | Filed herewith. | ||||||||||||||||
# | Furnished herewith. | ||||||||||||||||
** | Management contract, compensatory plan or arrangement. |
Date: May 8, 2025 | Inseego Corp. | |||||||||||||
By: | /s/ JUHO SARVIKAS | |||||||||||||
Juho Sarvikas | ||||||||||||||
Chief Executive Officer |
By: | /s/ STEVEN GATOFF | |||||||||||||
Steven Gatoff | ||||||||||||||
Chief Financial Officer |
(a) | Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared; | ||||
(b) | Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles; | ||||
(c) | Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and | ||||
(d) | Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and |
(a) | All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and | ||||
(b) | Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting. |
/s/ Juho Sarvikas | ||
Juho Sarvikas | ||
Chief Executive Officer (principal executive officer) |
(a) | Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared; | ||||
(b) | Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles; | ||||
(c) | Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and | ||||
(d) | Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and |
(a) | All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and | ||||
(b) | Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting. |
/s/ Steven Gatoff | ||
Steven Gatoff | ||
Chief Financial Officer (principal financial officer) |
• | the Quarterly Report on Form 10-Q of the Company for the quarter ended March 31, 2025 (the “Report”) fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and |
• | the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. |
/s/ Juho Sarvikas | ||
Juho Sarvikas | ||
Chief Executive Officer (principal executive officer) |
• | the Quarterly Report on Form 10-Q of the Company for the quarter ended March 31, 2025 (the “Report”) fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and |
• | the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. |
/s/ Steven Gatoff | ||
Steven Gatoff | ||
Chief Financial Officer (principal financial officer) |
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ DEFICIT - USD ($) $ in Thousands |
Total |
Preferred Stock |
Common Stock |
Additional Paid-in Capital |
[1] | Accumulated Deficit |
Accumulated Other Comprehensive (Loss) Income |
|||
---|---|---|---|---|---|---|---|---|---|---|
Preferred stock, beginning balance (in shares) at Dec. 31, 2023 | 25,000 | |||||||||
Beginning balance at Dec. 31, 2023 | $ (102,105) | $ 0 | $ 12 | [1] | $ 810,138 | $ (906,928) | $ (5,327) | |||
Beginning balance, shares (in shares) at Dec. 31, 2023 | [1] | 11,879,000 | ||||||||
Increase (Decrease) in Stockholders' Equity [Roll Forward] | ||||||||||
Net income (loss) | (4,455) | (4,455) | ||||||||
Foreign currency translation adjustment | 262 | 262 | ||||||||
Exercises of stock options, vesting of restricted stock units and stock issued under employee stock purchase plan, net of taxes withheld (in shares) | [1] | 4,000 | ||||||||
Exercises of stock options, vesting of restricted stock units and stock issued under employee stock purchase plan, net of taxes withheld | (8) | (8) | ||||||||
Share-based compensation | 717 | 717 | ||||||||
Preferred stock dividends | 0 | 790 | (790) | |||||||
Preferred stock, ending balance (in shares) at Mar. 31, 2024 | 25,000 | |||||||||
Ending balance at Mar. 31, 2024 | (105,589) | $ 0 | $ 12 | [1] | 811,637 | (912,173) | (5,065) | |||
Ending balance, shares (in shares) at Mar. 31, 2024 | [1] | 11,883,000 | ||||||||
Preferred stock, beginning balance (in shares) at Dec. 31, 2024 | 25,000 | |||||||||
Beginning balance at Dec. 31, 2024 | $ (12,858) | $ 0 | $ 15 | [1] | 892,534 | (905,625) | 218 | |||
Beginning balance, shares (in shares) at Dec. 31, 2024 | 14,990,712 | 14,991,000 | [1] | |||||||
Increase (Decrease) in Stockholders' Equity [Roll Forward] | ||||||||||
Net income (loss) | $ (1,570) | (1,570) | ||||||||
Foreign currency translation adjustment | 6 | 6 | ||||||||
Exercises of stock options, vesting of restricted stock units and stock issued under employee stock purchase plan, net of taxes withheld (in shares) | [1] | 16,000 | ||||||||
Exercises of stock options, vesting of restricted stock units and stock issued under employee stock purchase plan, net of taxes withheld | (174) | (174) | ||||||||
Share-based compensation | 1,601 | 1,601 | ||||||||
Preferred stock dividends | 0 | 864 | (864) | |||||||
Preferred stock, ending balance (in shares) at Mar. 31, 2025 | 25,000 | |||||||||
Ending balance at Mar. 31, 2025 | $ (12,995) | $ 0 | $ 15 | [1] | $ 894,825 | $ (908,059) | $ 224 | |||
Ending balance, shares (in shares) at Mar. 31, 2025 | 15,007,437 | 15,007,000 | [1] | |||||||
|
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands |
3 Months Ended | |
---|---|---|
Mar. 31, 2025 |
Mar. 31, 2024 |
|
Cash flows from operating activities: | ||
Net income (loss) | $ (1,570) | $ (4,455) |
Adjustments to reconcile net loss to net cash used in (provided by) operating activities: | ||
(Income) Loss from discontinued operations, net of tax | 400 | (1,061) |
Depreciation and amortization | 2,098 | 3,338 |
Provision for expected credit losses | 14 | (41) |
Impairment of capitalized software | 384 | 420 |
Provision for excess and obsolete inventory | 680 | 128 |
Share-based compensation expense | 1,601 | 688 |
Amortization of debt discount and debt issuance costs | (22) | 489 |
Deferred income taxes | 3 | 3 |
Non-cash operating lease expense | 263 | 252 |
Changes in assets and liabilities: | ||
Accounts receivable | 1,698 | 238 |
Inventories | (2,218) | 1,880 |
Prepaid expenses and other assets | 1,346 | (460) |
Accounts payable | (850) | (734) |
Accrued expenses and other liabilities | (6,972) | 3,563 |
Operating lease liabilities | (322) | (306) |
Operating cash flows from continuing operations | (3,467) | 3,942 |
Operating cash flows from discontinued operations | 0 | 1,298 |
Net cash used in (provided by) operating activities | (3,467) | 5,240 |
Cash flows from investing activities: | ||
Purchases of property, plant and equipment | (32) | 0 |
Additions to capitalized software development costs and purchases of intangible assets | (1,693) | (577) |
Investing cash flows from continuing operations | (1,725) | (577) |
Investing cash flows from discontinued operations | 710 | 0 |
Net cash used in investing activities | (1,015) | (577) |
Cash flows from financing activities: | ||
Net borrowings on revolving credit facility | 0 | 583 |
Proceeds from stock option exercises and employee stock purchase plan, net of taxes | 42 | 0 |
Financing cash flows from continuing operations | 42 | 583 |
Financing cash flows from discontinued operations | 0 | 0 |
Net cash provided by financing activities | 42 | 583 |
Effect of exchange rates on cash | (7) | 226 |
Net decrease (increase) in cash and cash equivalents | (4,447) | 5,472 |
Cash and cash equivalents, beginning of period | 39,596 | 2,409 |
Cash and cash equivalents, end of period | 35,149 | 7,881 |
Cash paid during the year for: | ||
Interest | 7 | 147 |
Income taxes | 57 | 44 |
Supplemental disclosures of non-cash investing and financing activities: | ||
Capital expenditures financed through accounts payable or accrued liabilities | $ 918 | $ 104 |
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS (Parenthetical) - USD ($) $ in Thousands |
3 Months Ended | |
---|---|---|
Mar. 31, 2025 |
Mar. 31, 2024 |
|
Income Statement [Abstract] | ||
Discontinued operations tax provision | $ 400 | $ 220 |
Nature of Business and Significant Accounting Policies |
3 Months Ended |
---|---|
Mar. 31, 2025 | |
Accounting Policies [Abstract] | |
Nature of Business and Significant Accounting Policies | Nature of Business and Significant Accounting Policies Basis of Presentation and Consolidation The accompanying unaudited condensed consolidated financial statements (“Financial Statements”) have been prepared by Inseego Corp. (the “Company”, “we”, “us” or “our”) in accordance with accounting principles generally accepted in the U.S. (“GAAP”) and applicable rules and regulations of the Securities and Exchange Commission (“SEC”) regarding interim financial reporting. The Financial Statements include the accounts of the Company and its consolidated subsidiaries. All significant intercompany balances and transactions have been eliminated in consolidation. These Financial Statements should be read in conjunction with the audited consolidated financial statements and notes as of and for the year ended December 31, 2024, included in the Company's Annual Report on Form 10-K for the year ended December 31, 2024 (the “Form 10-K”). The condensed consolidated balance sheet as of December 31, 2024 was derived from the audited consolidated financial statements as of that date, but does not include all disclosures required by GAAP. In management’s opinion, the accompanying Financial Statements reflect all normal recurring adjustments necessary for their fair presentation. Other than described below, there have been no changes to the Company’s significant accounting policies described in the Form 10-K that have had a material impact on the Company’s Financial Statements. The results of operations for the interim periods presented are not necessarily indicative of results to be expected for any other interim period or for the year as a whole. Divestiture of the Telematics Business On November 27, 2024, the Company completed the previously announced sale of its fleet management and telematics solutions business, which has operations in the United Kingdom, Europe, Australia and New Zealand (the “Telematics Business”). The sale of the Telematics Business was completed pursuant to the Share Purchase Agreement, which was entered into on September 16, 2024 with Light Sabre SPV Limited (the “Purchase Agreement”). Pursuant to the terms of the Purchase Agreement, Ctrack Holdings (the “Purchaser”), as assignee of Light Sabre SPV Limited, acquired the entire issued share capital of the Company’s Inseego International Holdings Limited subsidiary for $52.0 million in an all-cash transaction (the “Sale Transaction”). The Purchase Agreement provided for a working capital adjustment, which was determined in December 2024 and funded in January 2025, resulting in an increase to the initial purchase consideration of $0.7 million as a result of changes in closing working capital and net debt. In accordance with the authoritative guidance for discontinued operations (Accounting Standards Codification (“ASC”) 205-20), the Company determined that the Telematics Business met the held-for sale and discontinued operations accounting criteria at the end of the third quarter of 2024. Accordingly, within these consolidated financial statements, the assets and liabilities associated with the Telematics Business disposal group prior to its sale have been classified as held for sale within the Consolidated Balance Sheets and its operations and cash flows have been classified as discontinued operations within the Condensed Consolidated Statements of Operations and Comprehensive Income and Condensed Consolidated Statements of Cash Flows. Refer to Note 2 – Discontinued Operations and Held for Sale for additional information regarding the Telematics Business, including the assets and liabilities divested and income from discontinued operations. Unless otherwise noted, disclosures within these remaining Notes to Condensed Consolidated Financial Statements relate solely to the Company's continuing operations. Held for Sale and Discontinued Operations The Company classifies assets and liabilities to be sold (disposal group) as held for sale in the period when all of the applicable criteria are met, including: (i) management commits to a plan to sell, (ii) the disposal group is available to sell in its present condition, (iii) there is an active program to locate a buyer, (iv) the disposal group is being actively marketed at a reasonable price in relation to its fair value, (v) significant changes to the plan to sell are unlikely, and (vi) the sale of the disposal group is generally probable of being completed within one year. Management performs an assessment at least quarterly or when events or changes in business circumstances indicate that a change in classification may be necessary. Assets and liabilities held for sale are presented separately within the Condensed Consolidated Balance Sheets with any adjustments necessary to measure the disposal group at the lower of its carrying value or fair value less costs to sell. Depreciation of property, plant and equipment and amortization of intangible and right-of-use assets are not recorded while these assets are classified as held for sale. For each period the disposal group remains classified as held for sale, its recoverability is reassessed and any necessary adjustments are made to its carrying value. No impairment upon classification as held for sale was recorded during the year ended December 31, 2024. The Company reports the results of operations of a business as discontinued operations if a disposal represents a strategic shift that will have a major effect on its operations and financial results. The results of discontinued operations are reported as Income from discontinued operations, net of tax in the Condensed Consolidated Statements of Operations and Comprehensive Income for the current and prior periods commencing in the period in which the held for sale criteria are met. Income from discontinued operations, net of tax includes direct costs attributable to the divested business and excludes any cost allocations associated with any shared or corporate functions unless otherwise dedicated to the divested business. Income from discontinued operations, net of tax will include any gain or loss recognized upon disposition or from adjustment of the carrying amount to fair value less costs to sell while classified as held for sale. Transactions between the businesses held for sale and businesses held for use that are expected to continue after the disposal are not eliminated in order to appropriately reflect the continuing operations as well as the activity to be disposed of. Interest costs are included as a component of Income from discontinued operations, net of tax for debt specifically attributable to the discontinued operation or debt that is obligated to be repaid in connection with the completion of the divestiture. Activity within comprehensive income directly associated with a divested business is not realized as a component of Income from discontinued operations, net of tax until completion of the sale or disposition. Reverse Stock Split On January 24, 2024, the Company completed a 1-for-10 reverse stock split of its issued and outstanding common stock (the “Reverse Stock Split”). As a result of the Reverse Stock Split, each share of common stock issued and outstanding immediately prior to January 24th was automatically converted into one-tenth (1/10) of a share of common stock. The Reverse Stock Split affected all common stockholders uniformly and did not alter any stockholder's percentage interest in the Company's equity, except to the extent that the Reverse Stock Split would result in a stockholder owning a fractional share. No fractional shares were issued in connection with the Reverse Stock Split. Stockholders who otherwise would be entitled to receive a fractional share instead were entitled to receive cash in lieu of such fractional share. The Reverse Stock Split did not change the par value of the common stock or the authorized number of shares of common stock. All outstanding convertible notes entitling their holders to purchase or obtain or convert into shares of our common stock were adjusted, as required by the terms of these securities. All common share and per-share amounts in this Form 10-Q have been retroactively restated to reflect the effect of the Reverse Stock Split. Segment Information The Company has one reportable segment. The Company’s Executive Chairman, who was the Company’s Chief Operating Decision Maker (“CODM”) as of December 31, 2024, left the Company in February 2025, at which point, the Company’s CODM became its Chief Executive Officer (“CEO”). Neither of these CODMs manage any part of the Company separately, and the allocation of resources and assessment of performance is based solely on the Company’s consolidated operations and financial results. See Note 9 – Segment, Geographic, and Concentrations of Risk Information for more information. Use of Estimates The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions. These estimates and assumptions affect the reported amounts of assets, liabilities, revenues and expenses, and the disclosure of contingent liabilities. Actual results could differ materially from these estimates. Estimates are assessed each period and updated to reflect current information. Significant estimates include revenue recognition, capitalized software costs, allowance for credit losses, provision for excess and obsolete inventory, accrued liabilities related to our contract manufacturers, valuation of tangible and intangible long-lived assets, valuation of goodwill, valuation of derivatives, accruals relating to litigation, income taxes and share-based compensation expense. Reclassifications Certain amounts recorded in the prior period consolidated financial statements have been reclassified to conform to the current period financial statement presentation. These reclassifications had no effect on previously reported operating results.
|
Discontinued Operations and Held for Sale |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2025 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Discontinued Operations and Disposal Groups [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Discontinued Operations and Held for Sale | Discontinued Operations and Held for Sale As noted in Note 1 – Nature of Business and Significant Accounting Policies, on September 16, 2024, the Company entered into the Purchase Agreement to sell its Telematics Business. On November 27, 2024, the Company completed the sale of its Telematics Business. The operating results of the discontinued operations only reflect revenues and expenses that are directly attributable to the Telematics Business. The following table summarizes Income from discontinued operations, net of tax included in the Condensed Consolidated Statements of Operations and Comprehensive Income for the three months ended March 31, 2025 and 2024 (in thousands):
Income taxes related to discontinued operations in the three months ended March 31, 2025 relate to the deregistration process for the Company’s remaining subsidiaries in South Africa, which do not have operations. As the sale of the Telematics Business was completed on November 27, 2024, there were no assets or liabilities held for sale as of either March 31, 2025 or December 31, 2024.
|
Financial Statement Details |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2025 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Organization, Consolidation and Presentation of Financial Statements [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Financial Statement Details | Financial Statement Details Inventories Inventories consist of the following (in thousands):
Prepaid expenses and other Prepaid expenses and other consists of the following (in thousands):
Accrued expenses and other current liabilities Accrued expenses and other current liabilities consist of the following (in thousands):
Other long-term liabilities Other long-term liabilities consist of the following (in thousands):
As of March 31, 2025, of the $2.6 million long-term deferred revenue balance, $2.5 million relates to performance obligations expected to be satisfied between one and two years, and $0.1 million relates to performance obligations expected to be satisfied between two and three years from March 31, 2025.
|
Fair Value Measurements |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2025 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Fair Value Disclosures [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Fair Value Measurements | Fair Value Measurements The following table sets forth the fair value of the financial assets and liabilities measured on a recurring basis and indicates the fair value hierarchy utilized to determine such fair value (in thousands):
No transfers between levels occurred during the three months ended March 31, 2025 or March 31, 2024. The Company also has an interest make-whole payment derivative liability on its 2025 Convertible Notes (as defined in Note 5 – Debt) that is measured at fair value on a recurring basis. The fair value of that liability was zero as of both March 31, 2025 and December 31, 2024. The interest make-whole payment derivative liability is a Level 3 instrument and was valued using a Monte Carlo model. During the three months ended March 31, 2025 and 2024, there were no conversions of the 2025 Convertible Notes into shares of the Company’s common stock. There was also no change in the fair value of the interest make-whole liability for the three months ended March 31, 2025 or March 31, 2024. Other Financial Instruments The carrying values of the Company’s other financial assets and liabilities approximate their fair values because of their short-term nature, with the exception of the 2029 Senior Secured Notes (as defined in Note 5 – Debt) and 2025 Convertible Notes. The 2029 Senior Secured Notes and 2025 Convertible Notes are carried at amortized cost, with the 2025 Convertible notes being adjusted for changes in fair value of the embedded interest make-whole payment derivative.
|
Debt |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2025 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt Disclosure [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt | Debt 2029 Senior Secured Notes On November 6, 2024, the Company issued to multiple noteholders approximately $40.9 million in principal amount of new senior secured notes due in 2029 (the “2029 Senior Secured Notes”). The 2029 Senior Secured Notes bear interest at 9.0% per annum, to be paid in cash, in arrears, on a semi-annual basis, and have a maturity date of May 1, 2029. The Company may, subject to certain provisions, issue additional principal amounts of the 2029 Senior Secured Notes with the same terms as the notes issued on November 6, 2024, with the exception of the first date on which interest expense begins to accrue. The 2029 Senior Secured Notes are secured by a first priority lien on substantially all of the Company’s assets. The Company may redeem all or part of the 2029 Senior Secured Notes at any time prior to May 1, 2029 at a redemption price equal to 100% of the principal amount of the 2029 Senior Secured Notes to be redeemed, plus the present value of the sum of all required interest payments from such redemption date through May 1, 2029 at such redemption date, plus accrued and unpaid interest on such 2029 Senior Secured Notes to, but excluding, the redemption date. As of March 31, 2025, $40.9 million of principal of the 2029 Senior Secured Notes was outstanding, $31.8 million of which was held by related parties. The 2029 Senior Secured Notes, net consists of the following (in thousands):
2025 Convertible Notes In 2020, the Company completed both a registered public offering and a privately negotiated exchange agreement that resulted in the issuance of 3.25% convertible senior notes due in 2025 (the “2025 Convertible Notes”). The 2025 Convertible Notes matured on May 1, 2025. The 2025 Convertible Notes were senior unsecured obligations of the Company and bore interest at an annual rate of 3.25%, which was payable semi-annually in arrears on May 1 and November 1 of each year. Repurchases and Exchanges of 2025 Convertible Note Throughout the year ended December 31, 2024, the Company entered into a series of repurchase and exchange agreements with various holders of the Company’s 2025 Convertible Notes, some of whom were considered related parties of the Company. In summary, as a result of these repurchase and exchange agreements, the Company exchanged $146.9 million of outstanding principal of the 2025 Convertible Notes in exchange for $33.8 million of cash, $40.9 million of principal of the 2029 Senior Secured Notes, 2.9 million shares of the Company’s common stock, and warrants to purchase an aggregate of approximately 2.5 million shares of the Company’s common stock. As of both March 31, 2025 and December 31, 2024, $14.9 million of principal amount of the 2025 Convertible Notes was outstanding, none of which was held by related parties. The 2025 Convertible Notes consist of the following (in thousands):
The 2025 Convertible Notes reached maturity and were repaid in full, including all accrued interest, on May 1, 2025. Asset-backed Revolving Credit Facility In August 2022, the Company entered into a Loan and Security Agreement (as subsequently amended, the “Credit Agreement”), by and among Siena Lending Group LLC, as lender (“Lender”), Inseego Wireless, Inc., a Delaware corporation (“Inseego Wireless”), a subsidiary of the Company, and Inseego North America LLC, an Oregon limited liability company and indirect subsidiary of the Company, as borrowers (together with Inseego Wireless, the “Borrowers”), and the Company, as guarantor (together with the Borrowers, the “Credit Facility Parties”). The Credit Agreement established a secured asset-backed revolving credit facility which was comprised of a maximum $50 million revolving credit facility (“Credit Facility”), with a minimum borrowing amount for interest calculations of $4.5 million upon execution of the Credit Agreement. Availability under the Credit Facility was determined monthly by a borrowing base comprised of a percentage of eligible accounts receivable and eligible inventory of the Borrowers. Outstanding amounts exceeding the borrowing base were to be repaid immediately. The Borrowers’ obligations under the Credit Agreement were guaranteed by the Company. The Credit Facility Parties’ obligations under the Credit Agreement were secured by a continuing security interest in all property of each Credit Facility Party, subject to certain Excluded Collateral (as defined in the Credit Agreement). On May 2, 2023, (1) two related parties, South Ocean Funding, LLC and North Sound Ventures, LP (collectively, the “Credit Facility Participants”) collectively purchased a $4.0 million last-out subordinated participation interest in the Credit Agreement (the “Credit Facility Participation Interest”) from the Lender, and (2) the Borrowers entered into an amendment to the Credit Agreement which increased the borrowing base under the Credit Facility by $4.0 million, increased the minimum borrowing amount for interest calculations to $8.5 million, and modified certain covenants. In connection with the purchase of the Credit Facility Participation Interest, we agreed to pay the Credit Facility Participants an aggregate exit fee (the “Exit Fee”) ranging from 7.5% to 12.5% of the amount of the Credit Facility Participation Interest, payable upon the earlier to occur of (a) the maturity date of the Credit Facility, (b) termination of the Lender’s commitment to make revolving loans prior to the scheduled maturity date of the Credit Facility, and (c) the early redemption of the Credit Facility Participation Interest, as applicable. Further, the purchase of the Credit Facility Participation Interest granted an option for the Credit Facility Participants to purchase the subject revolving loan or to redeem its Credit Facility Participation Interest under certain circumstances. The Credit Facility Participants are each affiliates of beneficial holders of greater than five percent of our outstanding common stock. Effective April 18, 2024, the Company exercised its right to voluntarily pay-off and terminate the Credit Facility. Interest Expense, Summary The following table sets forth total interest expense, annualized effective interest rate, and interest expense related to related parties, if applicable, for each of the debt instruments detailed above (in thousands, except for percentages):
The annualized effective interest rates, including the impact of non-cash interest expense, for the 2029 Senior Secured Notes and 2025 Convertible Notes for the three months ended March 31, 2025 was 8.5% and 4.1%, respectively. The annualized effective interest rates, including the impact of non-cash interest expense, for the 2025 Convertible Notes and Credit Facility for the three months ended March 31, 2024 was 4.2% and 29.7%, respectively.
|
Share-based Compensation |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2025 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Share-Based Payment Arrangement [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Share-based Compensation | Share-based Compensation During the three months ended March 31, 2025 and 2024, the Company granted awards under the 2018 Omnibus Incentive Compensation Plan, previously named the Amended and Restated 2009 Omnibus Incentive Compensation Plan (the “2018 Plan”), and the 2015 Incentive Compensation Plan (the “2015 Plan”). The Compensation Committee of the Board of Directors administers the plans. Under the 2018 Plan, shares of common stock may be issued upon the exercise of stock options, in the form of restricted stock, or in settlement of restricted stock units (“RSUs”) or other awards, including awards with alternative vesting schedules such as performance-based criteria. The 2018 Plan authorizes 5,775,308 shares, of which 2,681,632 remain available for future grants as of March 31, 2025. The following table presents total share-based compensation expense within each functional line item on the condensed consolidated statements of operations for the three months ended March 31, 2025 and 2024 (in thousands):
Stock Options The Compensation Committee of the Board of Directors determines eligibility, vesting schedules and exercise prices for stock options granted. The Company generally uses the Black-Scholes option pricing model to estimate the fair value of its stock options, which generally only include time-based vesting requirements. Stock options generally have a term of ten years and vest over a to four-year period. The following table summarizes the Company’s stock option activity for the three months ended March 31, 2025:
During the three months ended March 31, 2025, the Company granted stock options to the CEO in connection with his hiring on January 6, 2025. These stock options contain a requirement that in order to be exercisable, the Company’s closing stock price must exceed the exercise price of the awards for 20 of the 30 trading-days immediately prior to the requested exercise date. The Company granted a total of 850,000 of these options to the CEO at a weighted average exercise price of $18.46. The total grant-date fair value of the options was $6.7 million and will be expensed over the four-year vesting term of the awards. These options granted to the Company’s CEO were valued using a Monte Carlo simulation model. The following table details the key assumptions utilized in the Monte Carlo simulation model used to calculate the grant-date fair value of the awards:
At March 31, 2025, total unrecognized compensation expense related to stock options was $5.4 million, which is expected to be recognized over a weighted-average period of 3.68 years. Restricted Stock Units Pursuant to the 2018 Plan and the 2015 Plan, the Company may issue RSUs that, upon satisfaction of vesting conditions, allow recipients to receive common stock. Issuances of such awards reduce common stock available under the 2018 Plan and 2015 Plan for stock incentive awards. The Company measures compensation cost associated with grants of RSUs at fair value, which is generally the closing price of the Company’s stock on the date of grant. RSUs generally vest over a - to four-year period. The following table summarizes the Company’s RSU activity for the three months ended March 31, 2025:
During the three months ended March 31, 2025, the Company granted RSUs to the CEO in connection with his hiring on January 6, 2025. The Company granted the CEO 124,347 RSUs that contain a time-based vesting requirement (“Time-based CEO RSUs”) with a total grant-date fair value of $1.4 million that vest over four years. The Company also granted the CEO RSUs that contain a market-based vesting condition in addition to a time-based vesting requirement (“Market-based CEO RSUs”). The Company granted 167,910 of these Market-based CEO RSUs with a total grant-date fair value of $3.2 million that will be expensed over the three-year vesting term of the awards. The actual number of shares to be issued upon completion of the time-based vesting requirement of the Market-based CEO RSUs is dependent upon the Company’s share price performance relative to the total shareholder return of Russell Microcap Index (“rTSR”) over the vesting period, ranging from 0% to 200% of the number of market-based RSUs granted. The following table details the key assumptions utilized in the Monte Carlo simulation model used to calculate the grant-date fair value of the Market-based CEO RSUs:
At March 31, 2025, total unrecognized compensation expense related to RSUs, including the RSUs with a market based condition discussed above, was $9.2 million, which is expected to be recognized over a weighted-average period of 3.23 years.
|
Earnings (Loss) per Share |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2025 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Earnings Per Share [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Earnings (Loss) per Share | Earnings (Loss) per Share Basic earnings (loss) per share (“EPS”) excludes dilution and is computed by dividing net loss attributable to common stockholders by the weighted-average number of common shares outstanding for the period. Diluted EPS reflects the potential dilution that could occur if securities or other contracts to issue common stock were exercised or converted into common stock using the treasury stock method. Potentially dilutive securities (consisting primarily of the 2025 Convertible Notes calculated using the if-converted method and warrants, stock options and RSUs calculated using the treasury stock method) are excluded from the diluted EPS computation in loss periods and when their effect would be anti-dilutive. The calculation of basic and diluted EPS was as follows (in thousands, except per share data):
(**) Rounding may affect summation. The following is a summary of outstanding anti-dilutive potential shares of common stock that have been excluded from diluted net loss per share attributable to common stockholders because their inclusion would have been anti-dilutive as of March 31, 2025 and 2024 (in thousands):
|
Stockholders' Equity (Deficit) |
3 Months Ended | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2025 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Equity [Abstract] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stockholders' Equity (Deficit) | Stockholders' Equity (Deficit) Warrants In connection with various debt restructuring agreements entered into during the year ended December 31, 2024, the Company issued warrants to purchase an aggregate of 3.0 million shares of the Company’s common stock, including the warrants noted in Note 5 – Debt. The warrants expire four years from their date of issuance and are exercisable on a cash basis at any time before their expiration dates. The warrants are subject to adjustment for stock splits, reverse stock splits, stock dividends and similar transactions and contain customary registration rights with respect to the shares of common stock issuable upon exercise of the warrants. The warrants issued during the year ended December 31, 2024 are the only outstanding warrants as of both March 31, 2025 and December 31, 2024. As of March 31, 2025, none of the warrants have been exercised. The number and exercise price of the warrants issued and outstanding as of March 31, 2025 are as follows:
Preferred Stock The Company has a total of 2,000,000 shares of preferred stock authorized for issuance at a par value of $0.001 per share, 150,000 of which have been designated Series D Preferred Stock and 39,500 of which have been designated Series E Preferred Stock. As of March 31, 2025 and December 31, 2024, the Company had 25,000 shares of Series E preferred stock issued and outstanding. Dividends declared, but not paid, related to the Series E Preferred Stock resulted in $14.3 million and $13.4 million of dividends accrued, approximating $570.26 and $535.71 per preferred share, as of March 31, 2025 and December 31, 2024, respectively.
|
Segment, Geographic, and Concentrations of Risk Information |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2025 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Segment Reporting [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Segment, Geographic, and Concentrations of Risk Information | Segment, Geographic, and Concentrations of Risk Information Segment Information As previously detailed in Note 1 – Nature of Business and Significant Accounting Policies, the Company operates as one reportable segment. As of March 31, 2025, the Company’s CODM was its CEO. The Company’s CODM does not manage any part of the Company separately, and the allocation of resources and assessment of performance is based solely on the Company’s consolidated operations and financial results. The accounting policies of our single reportable segment are the same as those described in Note 1 – Nature of Business and Significant Accounting Policies. The CODM uses net income (loss) in evaluating the performance of our single reportable segment and determining how to allocate resources of the Company as a whole, including investing in our products, services and customers. As the Company only has one reportable segment, the measure of segment assets is reported on the balance sheet as total consolidated assets. The following table details the revenues, significant expenses and other segment items regularly provided to the CODM:
Geographic Information The following table details the Company’s revenues by geographic region based on shipping destination (in thousands):
Substantially all of the Company’s long-term assets are located within the United States. Concentrations of Credit Risk Customer Concentrations For the three months ended March 31, 2025, two customers accounted for 54.6% and 35.1% of revenues, respectively. For the three months ended March 31, 2024, two customers accounted for 47.2% and 21.9% of revenues, respectively. As of March 31, 2025, two customers accounted for 45.6% and 31.4% of accounts receivable, net, respectively. As of December 31, 2024, three customers accounted for 33.6%, 22.8%, and 18.8% of accounts receivable, net, respectively. Concentrations in the Available Sources of Supply of Materials and Product Our services use hardware and software from various third parties, some of which are procured from sole-source suppliers. For example, our MiFi mobile hotspots and fixed wireless access devices rely substantially on chipsets from Qualcomm. From time to time, certain components used in our products or solutions have been in short supply or their anticipated commercial introduction has been delayed or their availability has been interrupted for reasons outside our control. In addition, many of our suppliers are located outside of the United States and therefore can be impacted by additional government regulations, such as import tariffs.
|
Commitments and Contingencies |
3 Months Ended |
---|---|
Mar. 31, 2025 | |
Commitments and Contingencies Disclosure [Abstract] | |
Commitments and Contingencies | Commitments and Contingencies Noncancellable Purchase Obligations The Company typically enters into commitments with its contract manufacturers that require future purchases of goods or services in the three to four quarters following the balance sheet date. Such commitments are noncancellable (“noncancellable purchase obligations”). As of March 31, 2025, future payments under these noncancellable purchase obligations were approximately $44.1 million. Legal The Company is, from time to time, party to various legal proceedings arising in the ordinary course of business. The Company is regularly required to directly or indirectly participate in other U.S. patent infringement actions pursuant to its contractual indemnification obligations to certain customers. Based on an evaluation of these matters the Company currently believes that liabilities arising from, or sums paid in settlement of these existing matters, if any, would not have a material adverse effect on its consolidated results of operations or financial condition. Indemnification In the normal course of business, the Company periodically enters into agreements that require the Company to indemnify and defend its customers for, among other things, claims alleging that the Company’s products infringe upon third-party patents or other intellectual property rights. The Company’s maximum exposure under these indemnification provisions cannot be estimated but the Company does not believe that there are any matters individually or collectively that would have a material adverse effect on its consolidated results of operations or financial condition.
|
Income Taxes |
3 Months Ended |
---|---|
Mar. 31, 2025 | |
Income Tax Disclosure [Abstract] | |
Income Taxes | Income Taxes Income taxes for both periods consisted primarily of foreign income taxes at certain of the Company’s international entities and state taxes for its U.S.-based entities. The Company’s income tax expense differs from the expected expense based on statutory rates primarily due to full valuation allowances at all of its U.S.-based entities.
|
Pay vs Performance Disclosure - USD ($) $ in Thousands |
3 Months Ended | |
---|---|---|
Mar. 31, 2025 |
Mar. 31, 2024 |
|
Pay vs Performance Disclosure | ||
Net Income (Loss) | $ (1,570) | $ (4,455) |
Insider Trading Arrangements |
3 Months Ended |
---|---|
Mar. 31, 2025 | |
Trading Arrangements, by Individual | |
Rule 10b5-1 Arrangement Adopted | false |
Non-Rule 10b5-1 Arrangement Adopted | false |
Rule 10b5-1 Arrangement Terminated | false |
Non-Rule 10b5-1 Arrangement Terminated | false |
Nature of Business and Significant Accounting Policies (Policies) |
3 Months Ended |
---|---|
Mar. 31, 2025 | |
Accounting Policies [Abstract] | |
Basis of Presentation | Basis of Presentation and Consolidation The accompanying unaudited condensed consolidated financial statements (“Financial Statements”) have been prepared by Inseego Corp. (the “Company”, “we”, “us” or “our”) in accordance with accounting principles generally accepted in the U.S. (“GAAP”) and applicable rules and regulations of the Securities and Exchange Commission (“SEC”) regarding interim financial reporting. The Financial Statements include the accounts of the Company and its consolidated subsidiaries. All significant intercompany balances and transactions have been eliminated in consolidation. These Financial Statements should be read in conjunction with the audited consolidated financial statements and notes as of and for the year ended December 31, 2024, included in the Company's Annual Report on Form 10-K for the year ended December 31, 2024 (the “Form 10-K”). The condensed consolidated balance sheet as of December 31, 2024 was derived from the audited consolidated financial statements as of that date, but does not include all disclosures required by GAAP. In management’s opinion, the accompanying Financial Statements reflect all normal recurring adjustments necessary for their fair presentation. Other than described below, there have been no changes to the Company’s significant accounting policies described in the Form 10-K that have had a material impact on the Company’s Financial Statements. The results of operations for the interim periods presented are not necessarily indicative of results to be expected for any other interim period or for the year as a whole.
|
Principles of Consolidation | Basis of Presentation and Consolidation The accompanying unaudited condensed consolidated financial statements (“Financial Statements”) have been prepared by Inseego Corp. (the “Company”, “we”, “us” or “our”) in accordance with accounting principles generally accepted in the U.S. (“GAAP”) and applicable rules and regulations of the Securities and Exchange Commission (“SEC”) regarding interim financial reporting. The Financial Statements include the accounts of the Company and its consolidated subsidiaries. All significant intercompany balances and transactions have been eliminated in consolidation. These Financial Statements should be read in conjunction with the audited consolidated financial statements and notes as of and for the year ended December 31, 2024, included in the Company's Annual Report on Form 10-K for the year ended December 31, 2024 (the “Form 10-K”). The condensed consolidated balance sheet as of December 31, 2024 was derived from the audited consolidated financial statements as of that date, but does not include all disclosures required by GAAP. In management’s opinion, the accompanying Financial Statements reflect all normal recurring adjustments necessary for their fair presentation. Other than described below, there have been no changes to the Company’s significant accounting policies described in the Form 10-K that have had a material impact on the Company’s Financial Statements. The results of operations for the interim periods presented are not necessarily indicative of results to be expected for any other interim period or for the year as a whole.
|
Held for Sale and Discontinued Operations | In accordance with the authoritative guidance for discontinued operations (Accounting Standards Codification (“ASC”) 205-20), the Company determined that the Telematics Business met the held-for sale and discontinued operations accounting criteria at the end of the third quarter of 2024. Accordingly, within these consolidated financial statements, the assets and liabilities associated with the Telematics Business disposal group prior to its sale have been classified as held for sale within the Consolidated Balance Sheets and its operations and cash flows have been classified as discontinued operations within the Condensed Consolidated Statements of Operations and Comprehensive Income and Condensed Consolidated Statements of Cash Flows. Held for Sale and Discontinued Operations The Company classifies assets and liabilities to be sold (disposal group) as held for sale in the period when all of the applicable criteria are met, including: (i) management commits to a plan to sell, (ii) the disposal group is available to sell in its present condition, (iii) there is an active program to locate a buyer, (iv) the disposal group is being actively marketed at a reasonable price in relation to its fair value, (v) significant changes to the plan to sell are unlikely, and (vi) the sale of the disposal group is generally probable of being completed within one year. Management performs an assessment at least quarterly or when events or changes in business circumstances indicate that a change in classification may be necessary. Assets and liabilities held for sale are presented separately within the Condensed Consolidated Balance Sheets with any adjustments necessary to measure the disposal group at the lower of its carrying value or fair value less costs to sell. Depreciation of property, plant and equipment and amortization of intangible and right-of-use assets are not recorded while these assets are classified as held for sale. For each period the disposal group remains classified as held for sale, its recoverability is reassessed and any necessary adjustments are made to its carrying value. No impairment upon classification as held for sale was recorded during the year ended December 31, 2024. The Company reports the results of operations of a business as discontinued operations if a disposal represents a strategic shift that will have a major effect on its operations and financial results. The results of discontinued operations are reported as Income from discontinued operations, net of tax in the Condensed Consolidated Statements of Operations and Comprehensive Income for the current and prior periods commencing in the period in which the held for sale criteria are met. Income from discontinued operations, net of tax includes direct costs attributable to the divested business and excludes any cost allocations associated with any shared or corporate functions unless otherwise dedicated to the divested business. Income from discontinued operations, net of tax will include any gain or loss recognized upon disposition or from adjustment of the carrying amount to fair value less costs to sell while classified as held for sale. Transactions between the businesses held for sale and businesses held for use that are expected to continue after the disposal are not eliminated in order to appropriately reflect the continuing operations as well as the activity to be disposed of. Interest costs are included as a component of Income from discontinued operations, net of tax for debt specifically attributable to the discontinued operation or debt that is obligated to be repaid in connection with the completion of the divestiture. Activity within comprehensive income directly associated with a divested business is not realized as a component of Income from discontinued operations, net of tax until completion of the sale or disposition.
|
Segment Information | Segment Information The Company has one reportable segment. The Company’s Executive Chairman, who was the Company’s Chief Operating Decision Maker (“CODM”) as of December 31, 2024, left the Company in February 2025, at which point, the Company’s CODM became its Chief Executive Officer (“CEO”). Neither of these CODMs manage any part of the Company separately, and the allocation of resources and assessment of performance is based solely on the Company’s consolidated operations and financial results.
|
Use of Estimates | Use of Estimates The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions. These estimates and assumptions affect the reported amounts of assets, liabilities, revenues and expenses, and the disclosure of contingent liabilities. Actual results could differ materially from these estimates. Estimates are assessed each period and updated to reflect current information. Significant estimates include revenue recognition, capitalized software costs, allowance for credit losses, provision for excess and obsolete inventory, accrued liabilities related to our contract manufacturers, valuation of tangible and intangible long-lived assets, valuation of goodwill, valuation of derivatives, accruals relating to litigation, income taxes and share-based compensation expense.
|
Reclassifications | Reclassifications Certain amounts recorded in the prior period consolidated financial statements have been reclassified to conform to the current period financial statement presentation. These reclassifications had no effect on previously reported operating results.
|
Discontinued Operations and Held for Sale (Tables) |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2025 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Discontinued Operations and Disposal Groups [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of Discontinued Operations, Condensed Consolidated Statements of Operations, Comprehensive Income | The following table summarizes Income from discontinued operations, net of tax included in the Condensed Consolidated Statements of Operations and Comprehensive Income for the three months ended March 31, 2025 and 2024 (in thousands):
|
Financial Statement Details (Tables) |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2025 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Organization, Consolidation and Presentation of Financial Statements [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of Inventories | Inventories consist of the following (in thousands):
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of Prepaid Expenses and Other | Prepaid expenses and other consists of the following (in thousands):
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of Accrued Expenses and Other Current Liabilities | Accrued expenses and other current liabilities consist of the following (in thousands):
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of Other Long-term Liabilities | Other long-term liabilities consist of the following (in thousands):
|
Fair Value Measurements (Tables) |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2025 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Fair Value Disclosures [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis | The following table sets forth the fair value of the financial assets and liabilities measured on a recurring basis and indicates the fair value hierarchy utilized to determine such fair value (in thousands):
|
Debt (Tables) |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2025 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt Disclosure [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of Net Carrying Amount of Debt | The 2029 Senior Secured Notes, net consists of the following (in thousands):
The 2025 Convertible Notes consist of the following (in thousands):
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of Interest Expense | The following table sets forth total interest expense, annualized effective interest rate, and interest expense related to related parties, if applicable, for each of the debt instruments detailed above (in thousands, except for percentages):
|
Share-based Compensation (Tables) |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2025 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Share-Based Payment Arrangement [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of Share-based Compensation | The following table presents total share-based compensation expense within each functional line item on the condensed consolidated statements of operations for the three months ended March 31, 2025 and 2024 (in thousands):
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of Stock Option Activity | The following table summarizes the Company’s stock option activity for the three months ended March 31, 2025:
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of Stock Options, Valuation Assumptions | The following table details the key assumptions utilized in the Monte Carlo simulation model used to calculate the grant-date fair value of the awards:
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of Restricted Stock Unit Activity | The following table summarizes the Company’s RSU activity for the three months ended March 31, 2025:
|
Earnings (Loss) per Share (Tables) |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2025 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Earnings Per Share [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of Calculation of Basic and Diluted Earnings per Share | The calculation of basic and diluted EPS was as follows (in thousands, except per share data):
(**) Rounding may affect summation.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share | The following is a summary of outstanding anti-dilutive potential shares of common stock that have been excluded from diluted net loss per share attributable to common stockholders because their inclusion would have been anti-dilutive as of March 31, 2025 and 2024 (in thousands):
|
Stockholders' Equity (Deficit) (Tables) |
3 Months Ended | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2025 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Equity [Abstract] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of Stockholders' Equity Note, Warrants or Rights | The number and exercise price of the warrants issued and outstanding as of March 31, 2025 are as follows:
|
Segment, Geographic, and Concentrations of Risk Information (Tables) |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2025 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Segment Reporting [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of Segment Reporting Information, by Segment | The following table details the revenues, significant expenses and other segment items regularly provided to the CODM:
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of Geographic Concentration of Net Revenues | The following table details the Company’s revenues by geographic region based on shipping destination (in thousands):
|
Nature of Business and Significant Accounting Policies (Details) $ in Millions |
3 Months Ended | |||
---|---|---|---|---|
Jan. 24, 2024
shares
|
Mar. 31, 2025
segment
|
Jan. 31, 2025
USD ($)
|
Sep. 16, 2024
USD ($)
|
|
Product Information [Line Items] | ||||
Fractional shares issued (in shares) | shares | 0 | |||
Stock split, conversion ratio | 0.1 | |||
Number of reportable segments | segment | 1 | |||
Discontinued Operations, Held-for-Sale | Inseego International Holdings Limited | ||||
Product Information [Line Items] | ||||
Consideration for divestiture | $ 52.0 | |||
Increase in consideration due to closing working capital and debt | $ 0.7 |
Discontinued Operations and Held for Sale - Condensed Consolidated Statements of Operations and Comprehensive Income (Details) - USD ($) $ in Thousands |
3 Months Ended | |
---|---|---|
Mar. 31, 2025 |
Mar. 31, 2024 |
|
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items] | ||
Income (loss) from discontinued operations, net of tax | $ (400) | $ 1,061 |
Discontinued Operations, Held-for-Sale | Telematics Business | ||
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items] | ||
Gross profit from discontinued operations | 0 | 4,148 |
Research and development | 0 | 361 |
Sales and marketing | 0 | 1,155 |
General and administrative | 0 | 1,028 |
Depreciation and amortization | 0 | 343 |
Total operating costs and expenses | 0 | 2,887 |
Operating income from discontinued operations | 0 | 1,261 |
Interest income, net | 0 | 5 |
Other income (expense), net | 0 | 15 |
Income from discontinued operations before income taxes | 0 | 1,281 |
Income tax provision | 400 | 220 |
Income (loss) from discontinued operations, net of tax | (400) | 1,061 |
Discontinued Operations, Held-for-Sale | Telematics Business | Product | ||
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items] | ||
Gross profit from discontinued operations | 0 | 7,504 |
Discontinued Operations, Held-for-Sale | Telematics Business | Services and other | ||
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items] | ||
Gross profit from discontinued operations | $ 0 | $ 3,356 |
Financial Statement Details - Inventories, Net (Details) - USD ($) $ in Thousands |
Mar. 31, 2025 |
Dec. 31, 2024 |
---|---|---|
Organization, Consolidation and Presentation of Financial Statements [Abstract] | ||
Finished goods | $ 15,113 | $ 13,531 |
Raw materials and components | 0 | 44 |
Total inventories | $ 15,113 | $ 13,575 |
Financial Statement Details - Prepaid Expenses and Other (Details) - USD ($) $ in Thousands |
Mar. 31, 2025 |
Dec. 31, 2024 |
---|---|---|
Organization, Consolidation and Presentation of Financial Statements [Abstract] | ||
Rebate receivables | $ 1,201 | $ 3,495 |
Software licenses | 1,325 | 1,034 |
Other | 1,282 | 1,397 |
Total prepaid expenses and other | $ 3,808 | $ 5,926 |
Financial Statement Details - Accrued Expenses and Other Current Liabilities (Details) - USD ($) $ in Thousands |
Mar. 31, 2025 |
Dec. 31, 2024 |
---|---|---|
Organization, Consolidation and Presentation of Financial Statements [Abstract] | ||
Royalties | $ 460 | $ 954 |
Payroll and related expenses | 4,401 | 7,997 |
Accrued interest | 1,968 | 926 |
Deferred revenue | 9,438 | 9,245 |
Operating lease liabilities | 1,389 | 1,346 |
Accrued contract manufacturing liabilities | 4,841 | 4,772 |
Other | 3,569 | 4,893 |
Total accrued expenses and other current liabilities | $ 26,066 | $ 30,133 |
Financial Statement Details - Other Long-term Liabilities (Details) - USD ($) $ in Thousands |
Mar. 31, 2025 |
Dec. 31, 2024 |
---|---|---|
Organization, Consolidation and Presentation of Financial Statements [Abstract] | ||
Long-term deferred revenue | $ 2,567 | $ 4,608 |
Other | 147 | 147 |
Total other long-term liabilities | $ 2,714 | $ 4,755 |
Financial Statement Details - Narrative (Details) - USD ($) $ in Thousands |
Mar. 31, 2025 |
Dec. 31, 2024 |
---|---|---|
Organization, Consolidation and Presentation of Financial Statements [Abstract] | ||
Long-term deferred revenue | $ 2,567 | $ 4,608 |
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2025-04-01 | ||
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items] | ||
Performance obligation, amount | $ 2,500 | |
Revenue, remaining performance obligation, expected timing of satisfaction, period | 2 years | |
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2027-04-01 | ||
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items] | ||
Performance obligation, amount | $ 100 | |
Revenue, remaining performance obligation, expected timing of satisfaction, period | 3 years |
Fair Value Measurements - Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis (Details) $ in Thousands |
Mar. 31, 2025
USD ($)
|
---|---|
Assets: | |
Total cash equivalents | $ 33,406 |
Money market funds | |
Assets: | |
Total cash equivalents | 33,406 |
Level 1 | |
Assets: | |
Total cash equivalents | 33,406 |
Level 1 | Money market funds | |
Assets: | |
Total cash equivalents | 33,406 |
Level 2 | |
Assets: | |
Total cash equivalents | 0 |
Level 2 | Money market funds | |
Assets: | |
Total cash equivalents | 0 |
Level 3 | |
Assets: | |
Total cash equivalents | 0 |
Level 3 | Money market funds | |
Assets: | |
Total cash equivalents | $ 0 |
Fair Value Measurements - Narrative (Details) - USD ($) |
3 Months Ended | ||
---|---|---|---|
Mar. 31, 2025 |
Mar. 31, 2024 |
Dec. 31, 2024 |
|
Fair Value Measurement Inputs and Valuation Techniques [Line Items] | |||
Financial liabilities fair value | $ 0 | $ 0 | |
Gain on change in fair value of embedded derivative | 0 | $ 0 | |
2025 Notes | Convertible Debt | |||
Fair Value Measurement Inputs and Valuation Techniques [Line Items] | |||
2025 Convertible notes | $ 0 | $ 0 |
Debt - Narrative (Details) - USD ($) |
12 Months Ended | ||||||
---|---|---|---|---|---|---|---|
Nov. 06, 2024 |
May 02, 2023 |
Dec. 31, 2024 |
Mar. 31, 2025 |
Mar. 31, 2024 |
Aug. 31, 2022 |
Dec. 31, 2020 |
|
Debt Instrument [Line Items] | |||||||
Number of securities called by warrants or rights (in shares) | 3,018,304 | ||||||
Revolving Credit Facility | |||||||
Debt Instrument [Line Items] | |||||||
Debt aggregate face amount | $ 4,000,000 | ||||||
Maximum borrowing capacity | $ 50,000,000 | ||||||
Minimum draw | 8,500,000 | $ 4,500,000 | |||||
Line of credit increase | $ 4,000,000 | ||||||
Effective interest rate | 29.70% | ||||||
Revolving Credit Facility | Minimum | |||||||
Debt Instrument [Line Items] | |||||||
Commitment fee rate | 7.50% | ||||||
Revolving Credit Facility | Maximum | |||||||
Debt Instrument [Line Items] | |||||||
Commitment fee rate | 12.50% | ||||||
2029 Senior Secured Notes | Secured Debt | |||||||
Debt Instrument [Line Items] | |||||||
Debt aggregate face amount | $ 40,900,000 | ||||||
Stated interest rate of debt issued | 9.00% | ||||||
Redemption price as a percentage of principal amount | 100.00% | ||||||
Carrying amount of debt | $ 40,879,000 | $ 40,879,000 | |||||
Repurchased face amount | 40,900,000 | ||||||
Effective interest rate | 8.50% | ||||||
2029 Senior Secured Notes | Secured Debt | Related Party | |||||||
Debt Instrument [Line Items] | |||||||
Carrying amount of debt | $ 31,800,000 | ||||||
2025 Notes | Convertible Debt | |||||||
Debt Instrument [Line Items] | |||||||
Stated interest rate of debt issued | 3.25% | ||||||
Carrying amount of debt | 14,949,000 | $ 14,949,000 | |||||
Repurchased face amount | 146,900,000 | ||||||
Debt instrument, repurchase amount | $ 33,800,000 | ||||||
Issuance of common shares in connection with a public offering, net of issuance costs (in shares) | 2,900,000 | ||||||
Number of securities called by warrants or rights (in shares) | 2,500,000 | ||||||
Effective interest rate | 4.10% | 4.20% | |||||
2025 Notes | Convertible Debt | Related Party | |||||||
Debt Instrument [Line Items] | |||||||
Carrying amount of debt | $ 0 | $ 0 |
Debt - Components (Details) - USD ($) $ in Thousands |
Mar. 31, 2025 |
Dec. 31, 2024 |
---|---|---|
2029 Senior Secured Notes | Secured Debt | ||
Debt Instrument [Line Items] | ||
Principal | $ 40,879 | $ 40,879 |
Add: unamortized debt premium | 1,527 | 1,621 |
Less: unamortized issuance costs | (631) | (670) |
Net carrying amount | 41,775 | 41,830 |
2025 Notes | Convertible Debt | ||
Debt Instrument [Line Items] | ||
Principal | 14,949 | 14,949 |
Add: fair value of embedded derivative | 0 | 0 |
Less: unamortized debt discount | (6) | (25) |
Less: unamortized issuance costs | (5) | (19) |
Net carrying amount | $ 14,938 | $ 14,905 |
Debt - Interest Expense (Details) - USD ($) $ in Thousands |
3 Months Ended | |
---|---|---|
Mar. 31, 2025 |
Mar. 31, 2024 |
|
Debt Instrument [Line Items] | ||
Other interest expense | $ 7 | $ 78 |
Consolidated interest expense | 1,026 | 2,179 |
Revolving Credit Facility | ||
Debt Instrument [Line Items] | ||
Contractual interest expense | 0 | 222 |
Accretion of exit fee | 0 | 75 |
Amortization of debt issuance costs | 0 | 117 |
Total interest expense | 0 | 414 |
2029 Senior Secured Notes | Secured Debt | ||
Debt Instrument [Line Items] | ||
Contractual interest expense | 920 | 0 |
Amortization of debt issuance costs | 38 | 0 |
Amortization of debt discount/premium | (93) | 0 |
Total interest expense | 865 | 0 |
2029 Senior Secured Notes | Secured Debt | Related Party | ||
Debt Instrument [Line Items] | ||
Total interest expense | 672 | 0 |
2025 Notes | Convertible Debt | ||
Debt Instrument [Line Items] | ||
Contractual interest expense | 121 | 1,315 |
Amortization of debt issuance costs | 15 | 165 |
Amortization of debt discount/premium | 18 | 207 |
Total interest expense | 154 | 1,687 |
2025 Notes | Convertible Debt | Related Party | ||
Debt Instrument [Line Items] | ||
Total interest expense | $ 0 | $ 209 |
Share-based Compensation - Narrative (Details) $ / shares in Units, $ in Millions |
3 Months Ended |
---|---|
Mar. 31, 2025
USD ($)
tradingDay
$ / shares
shares
| |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |
Granted (in shares) | 893,000 |
Stock options | |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |
General term (in years) | 10 years |
Unrecognized expense | $ | $ 5.4 |
Recognition period | 3 years 8 months 4 days |
Stock options | 2018 Plan | |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |
Number of shares authorized under the plan (in shares) | 5,775,308 |
Shares available for future issuance or purchase (in shares) | 2,681,632 |
Stock options | CEO | |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |
Vesting period (in years) | 4 years |
Threshold of trading days | tradingDay | 20 |
Threshold of consecutive trading days | tradingDay | 30 |
Granted (in shares) | 850,000 |
Exercise price (in dollars per share) | $ / shares | $ 18.46 |
Grant date fair value | $ | $ 6.7 |
Stock options | Minimum | |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |
Vesting period (in years) | 3 years |
Stock options | Maximum | |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |
Vesting period (in years) | 4 years |
RSUs | |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |
Recognition period | 3 years 2 months 23 days |
Granted (in shares) | 338,776 |
Unrecognized expense, RSU | $ | $ 9.2 |
RSUs | Minimum | |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |
Vesting period (in years) | 3 years |
RSUs | Maximum | |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |
Vesting period (in years) | 4 years |
Restricted Stock Units, Time-Based Vesting | CEO | |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |
Vesting period (in years) | 4 years |
Granted (in shares) | 124,347 |
RSUs grant date fair value | $ | $ 1.4 |
Restricted Stock Units, Service And Market Based Vesting | CEO | |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |
Vesting period (in years) | 3 years |
Granted (in shares) | 167,910 |
RSUs grant date fair value | $ | $ 3.2 |
Restricted Stock Units, Service And Market Based Vesting | Minimum | CEO | |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |
Vesting range percentage | 0.00% |
Restricted Stock Units, Service And Market Based Vesting | Maximum | CEO | |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |
Vesting range percentage | 200.00% |
Share-based Compensation - Share-based Compensation (Details) - USD ($) $ in Thousands |
3 Months Ended | |
---|---|---|
Mar. 31, 2025 |
Mar. 31, 2024 |
|
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items] | ||
Share-based compensation expense | $ 1,601 | $ 717 |
Cost of revenues | ||
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items] | ||
Share-based compensation expense | 52 | 25 |
Research and development | ||
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items] | ||
Share-based compensation expense | 268 | 160 |
Sales and marketing | ||
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items] | ||
Share-based compensation expense | 146 | 164 |
General and administrative | ||
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items] | ||
Share-based compensation expense | 1,135 | 339 |
Income from discontinued operations, net of tax | ||
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items] | ||
Share-based compensation expense | $ 0 | $ 29 |
Share-based Compensation - Activity (Details) |
3 Months Ended |
---|---|
Mar. 31, 2025
shares
| |
Stock Options | |
Outstanding — beginning balance (in shares) | 269,851 |
Granted (in shares) | 893,000 |
Exercised (in shares) | (4,636) |
Cancelled (in shares) | (36,732) |
Outstanding — ending balance (in shares) | 1,121,483 |
Exercisable — ending balance (in shares) | 134,598 |
RSUs | |
Restricted Stock Units | |
Non-vested — beginning balance (in shares) | 1,111,841 |
Granted (in shares) | 338,776 |
Vested (in shares) | (51,534) |
Forfeited (in shares) | (81,277) |
Non-vested — ending balance (in shares) | 1,317,806 |
Share-based Compensation - Schedule of Stock Options, Valuation Assumptions (Details) - CEO |
Jan. 06, 2025
$ / shares
|
---|---|
Stock options | |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |
Valuation date stock price (in dollars per share) | $ 11.23 |
Simulation term (years) | 10 years |
Risk-free interest rate | 4.57% |
Volatility | 84.00% |
Expected dividend yield | 0.00% |
Restricted Stock Units, Service And Market Based Vesting | |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |
Valuation date stock price (in dollars per share) | $ 11.23 |
Simulation term (years) | 3 years |
Risk-free interest rate | 4.25% |
Volatility | 105.63% |
Expected dividend yield | 0.00% |
Correlation coefficient | 0.3741 |
Earnings (Loss) per Share - Calculation of Basic and Diluted Earnings per Share (Details) - USD ($) $ / shares in Units, $ in Thousands |
3 Months Ended | |||
---|---|---|---|---|
Mar. 31, 2025 |
Mar. 31, 2024 |
|||
Basic and Diluted EPS | ||||
Income (loss) from continuing operations | $ (1,170) | $ (5,516) | ||
Less: preferred stock dividends | (864) | (790) | ||
Income (loss) from continuing operations attributable to common stockholders | (2,034) | (6,306) | ||
Income from discontinued operations, net of tax | (400) | 1,061 | ||
Net income (loss) attributable to common stockholders | $ (2,434) | $ (5,245) | ||
Shares | ||||
Income (loss) from continuing operations/ discontinued operations attributable to common stockholders (in shares) | 15,002,003 | 11,879,719 | ||
Income (loss) attributable to common stockholders (in shares) | 15,002,003 | 11,879,719 | ||
Basic EPS | ||||
Income (loss) from continuing operations attributable to common stockholders (in dollars per share) | $ (0.14) | $ (0.53) | ||
Income from discontinued operations, net of tax (in dollars per share) | (0.03) | 0.09 | ||
Basic earnings per share (in dollars per share) | [1] | (0.16) | (0.44) | |
Diluted EPS | ||||
Income (loss) from continuing operations attributable to common stockholders (in dollars per share) | (0.14) | (0.53) | ||
Income from discontinued operations, net of tax (in dollars per share) | (0.03) | 0.09 | ||
Diluted earnings per share (in dollars per share) | [1] | $ (0.16) | $ (0.44) | |
|
Earnings (Loss) per Share - Antidilutive Securities Excluded from Computation of Earnings Per Share (Details) - shares shares in Thousands |
3 Months Ended | |
---|---|---|
Mar. 31, 2025 |
Mar. 31, 2024 |
|
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] | ||
Total (in shares) | 5,605 | 1,998 |
2025 Convertible Notes | ||
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] | ||
Total (in shares) | 119 | 1,338 |
Common stock warrants | ||
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] | ||
Total (in shares) | 3,018 | 0 |
Non-qualified stock options | ||
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] | ||
Total (in shares) | 1,121 | 448 |
Restricted stock units | ||
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] | ||
Total (in shares) | 1,318 | 186 |
Employee stock purchase plan | ||
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] | ||
Total (in shares) | 29 | 26 |
Stockholders' Equity (Deficit) - Narrative (Details) - USD ($) $ / shares in Units, $ in Millions |
3 Months Ended | 12 Months Ended |
---|---|---|
Mar. 31, 2025 |
Dec. 31, 2024 |
|
Class of Stock [Line Items] | ||
Number of securities called by warrants or rights (in shares) | 3,018,304 | |
Exercised price, loan warrants (in dollars per share) | $ 0 | |
Preferred stock, shares authorized (in shares) | 2,000,000 | 2,000,000 |
Preferred stock, par value (in dollars per share) | $ 0.001 | $ 0.001 |
Series D Preferred Stock | ||
Class of Stock [Line Items] | ||
Preferred stock, shares authorized (in shares) | 150,000 | |
Series E preferred stock | ||
Class of Stock [Line Items] | ||
Preferred stock, shares authorized (in shares) | 39,500 | 39,500 |
Preferred stock, par value (in dollars per share) | $ 0.001 | $ 0.001 |
Preferred stock issued (in shares) | 25,000 | 25,000 |
Preferred stock, shares outstanding (in shares) | 25,000 | 25,000 |
Dividends payable | $ 14.3 | $ 13.4 |
Dividends accrued (in dollars per share) | $ 570.26 | $ 535.71 |
2025 Convertible Notes, Long and Short Term Portions | Convertible Debt | ||
Class of Stock [Line Items] | ||
Number of securities called by warrants or rights (in shares) | 3,000,000 | |
2025 Notes | Convertible Debt | ||
Class of Stock [Line Items] | ||
Number of securities called by warrants or rights (in shares) | 2,500,000 | |
Warrant or right, reason for issuance expiry term | 4 years |
Stockholders' Equity (Deficit) - Issuance of Warrants (Details) |
Mar. 31, 2025
$ / shares
shares
|
---|---|
Class of Stock [Line Items] | |
Number of Shares to Purchase with Warrants (in shares) | 3,018,304 |
Warrants Issuance Date June 28, 2024 | |
Class of Stock [Line Items] | |
Number of Shares to Purchase with Warrants (in shares) | 550,000 |
Exercise price (in dollars per share) | $ / shares | $ 12.12 |
Warrants Issuance Date July 18, 2024 | |
Class of Stock [Line Items] | |
Number of Shares to Purchase with Warrants (in shares) | 236,074 |
Exercise price (in dollars per share) | $ / shares | $ 13.37 |
Warrants Issuance Date August 02, 2024 | |
Class of Stock [Line Items] | |
Number of Shares to Purchase with Warrants (in shares) | 88,534 |
Exercise price (in dollars per share) | $ / shares | $ 11.03 |
Warrants Issuance Date October 24, 2024 | |
Class of Stock [Line Items] | |
Number of Shares to Purchase with Warrants (in shares) | 20,646 |
Exercise price (in dollars per share) | $ / shares | $ 12.34 |
Warrant Issuance Date November 06, 2024, One | |
Class of Stock [Line Items] | |
Number of Shares to Purchase with Warrants (in shares) | 180,000 |
Exercise price (in dollars per share) | $ / shares | $ 11.27 |
Warrant Issuance Date November 06, 2024, Two | |
Class of Stock [Line Items] | |
Number of Shares to Purchase with Warrants (in shares) | 1,543,363 |
Exercise price (in dollars per share) | $ / shares | $ 12.12 |
Warrant Issuance Date November 06, 2024, Three | |
Class of Stock [Line Items] | |
Number of Shares to Purchase with Warrants (in shares) | 29,687 |
Exercise price (in dollars per share) | $ / shares | $ 12.34 |
Warrant Issuance Date November 06, 2024, Four | |
Class of Stock [Line Items] | |
Number of Shares to Purchase with Warrants (in shares) | 370,000 |
Exercise price (in dollars per share) | $ / shares | $ 15.77 |
Segment, Geographic, and Concentrations of Risk Information - Narrative (Details) - segment |
3 Months Ended | 12 Months Ended | |
---|---|---|---|
Mar. 31, 2025 |
Mar. 31, 2024 |
Dec. 31, 2024 |
|
Segment Reporting Information [Line Items] | |||
Number of reportable segments | 1 | ||
Net Revenues | Customer concentration risk | Customer one | |||
Segment Reporting Information [Line Items] | |||
Concentration percentage | 54.60% | 47.20% | |
Net Revenues | Customer concentration risk | Customer two | |||
Segment Reporting Information [Line Items] | |||
Concentration percentage | 35.10% | 21.90% | |
Accounts Receivable | Credit concentration risk | Customer one | |||
Segment Reporting Information [Line Items] | |||
Concentration percentage | 45.60% | 33.60% | |
Accounts Receivable | Credit concentration risk | Customer two | |||
Segment Reporting Information [Line Items] | |||
Concentration percentage | 31.40% | 22.80% | |
Accounts Receivable | Credit concentration risk | Customer three | |||
Segment Reporting Information [Line Items] | |||
Concentration percentage | 18.80% |
Segment, Geographic, and Concentrations of Risk Information - Revenues, Significant Expenses and Other Segment Items (Details) - USD ($) $ in Thousands |
3 Months Ended | |
---|---|---|
Mar. 31, 2025 |
Mar. 31, 2024 |
|
Segment Reporting Information [Line Items] | ||
Revenues | $ 31,673 | $ 37,505 |
Less: | ||
Share-based compensation | 1,601 | 717 |
Impairment of capitalized software | 384 | 420 |
Interest expense | 1,026 | 2,179 |
Other (income) expense, net | (303) | 375 |
Income tax provision | 23 | 17 |
Income (Loss) from continuing operations | (1,170) | (5,516) |
Income from discontinued operations, net of tax | (400) | 1,061 |
Net income (loss) | (1,570) | (4,455) |
Reportable Segment | ||
Segment Reporting Information [Line Items] | ||
Revenues | 31,673 | 37,505 |
Less: | ||
Adjusted cost of revenues | 16,638 | 24,236 |
Adjusted research and development | 4,267 | 4,523 |
Adjusted sales and marketing | 3,788 | 3,674 |
Adjusted general and administrative | 3,355 | 3,618 |
Adjusted depreciation and amortization | 1,748 | 2,962 |
Capitalizable software development expenditures | 2,376 | 583 |
Capitalized software development expenditures | (2,376) | (583) |
Share-based compensation | 1,601 | 687 |
Amortization of purchased intangible assets related to business combinations | 316 | 330 |
Impairment of capitalized software | 384 | 420 |
Interest expense | 1,026 | 2,179 |
Other (income) expense, net | (303) | 375 |
Income tax provision | 23 | 17 |
Income (Loss) from continuing operations | (1,170) | (5,516) |
Income from discontinued operations, net of tax | (400) | 1,061 |
Net income (loss) | $ (1,570) | $ (4,455) |
Segment, Geographic, and Concentrations of Risk Information - Net Revenues (Details) - USD ($) $ in Thousands |
3 Months Ended | |
---|---|---|
Mar. 31, 2025 |
Mar. 31, 2024 |
|
Revenues from External Customers and Long-Lived Assets [Line Items] | ||
Total | $ 31,673 | $ 37,505 |
United States and Canada | ||
Revenues from External Customers and Long-Lived Assets [Line Items] | ||
Total | 31,620 | 35,476 |
Europe (including United Kingdom) | ||
Revenues from External Customers and Long-Lived Assets [Line Items] | ||
Total | 0 | 701 |
Australia | ||
Revenues from External Customers and Long-Lived Assets [Line Items] | ||
Total | $ 53 | $ 1,328 |
Commitments and Contingencies (Details) $ in Millions |
Mar. 31, 2025
USD ($)
|
---|---|
Commitments and Contingencies Disclosure [Abstract] | |
Noncancellable purchase obligations | $ 44.1 |
4 +N3(VDD,Y%8S)_*=)6S_&O9OU6X*2?O)1I;M(ZGQ<;#F 40#4_RR7]A?_/(7O_S%
M+_\7_/*TXY>G>RGA9U4&*Z\E<$HFO]$.O@)X6FCTL0'T.6)3;+-?]/O["18"
MX@L#O$L:!<2ZU>$]Z9 /CS;=T>+!H!L$ NH !*7-A5&-@HEA;TS9$?P1/P]G/EO<)FY40"L]#)!*E2 #B
M5;WF@Y*"A1>!",0U#4FNXY6A]_ HDZX0*\RH;N=QNYP_/CB6J)$* ^J US^.
M3R9T6%70H(MSW]<@,)4*X[>%79+>[TCOA?C#"<7,G%#9&>EV!1*Q -5!@UP\
M& ?KX?TP1$_@+&T0>-@E4, 2! >%J0 -
MX)BP0;DW"G<9ZIGE#:P-&3S0-0<]G <&3=J-(-NK7S7J\0GU$?DNA=EJ\D7D
MD+_4#Q!*AR=N\5S%9PU^I^J"C"*?Q&& F9"E.6]08!O43
MMF;OWD3#\/T1LOV&;/\8^FQ!?9A5 D&MX)J)M!+,US,=KYCA*3"9P0 8IIV]XW:VD6%.X7- L[@;\3?@WA
MX K"7C@ M2$2CTZKF_),Y#7T@Y(R!(5K -\,-.X1=:)"^@/LLP!FH:B_B]4W4JRK3TN0TZ7(JLL5HX!=&<#SA8"Z8W>COE8U
M7R
E-_O,3' 8_VW!UY*R%$F]18I_WR3T522[[0HW5
M!K4>/ZS&J^:TF81P. I/!IM=#!:K411$6ZM6<-$VN,B;@G/*!:"+;7C65$1=
MIJ(C9RVTPRW:X0&IF.]AMD&N_40[DPV'PSC82XEIA3 :0GM*1ML@1]X@_\M&KXW=KXW^OG^I!Z0
M?D>\
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M5F\=$29*X_JF$2:8=[CS/J:^ FLD414VQ-NFC*-9N5<
N+=!+
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M0Y^_W/TU0WWTQ^P:G?Q\BGY&186^+_E&TBJ7YP,%:+3.0=8\^5/]9.QY
J4+V7AQ5A2F:[QNUN+"5+K0RCT[\CB;=C@J
MXCDOPSFG>\YY(-Z9QF^<>-V4JARO/X+,O>"G2?"7IW=N^$[:N7AP,A.GQZ>/
M[MCO06^(![S?@SW[36@I_G6V=-XB
"'W#L,
M0;)4*?O&%I\#Q+D%UI8-UK7F5M3=Y@+2#:8I.YMJTEU3F/D(F,-LS?&JZ4::
M9D=#OMS!#S0]V-O5JACH1'&I+?1JK0NT&WKE0WIM08(#":$AP*_DI-5*A0G
M!'/)YX$LYZWN?R]KM"KJ&=SZ]LO5>,8DFW!,7HL_F_2D^0!-.
M/ZXT1V$_VX-,:TFUQP(=74@NU,3?L)X3,H2W#@AFPRE#CJ?"UV
D%CJ50H%PP5CH#)04,ZFDEY30HMXB ^XYZMNTLI;QJ7=D;2UU)E/AR79O
MBURB%3;-UU!Y@OM.(-Y0CWFT)'T*KDKS7?LW4A.$J1RANK=#N&7G5C/PQ7@*
M\S=%M!0 Q T !D
M !X;"]W;W)K.!@B.L!.F0[95!
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MJ?,
3M@J!E0;=71[!Q-V8
M!>;7$(SJ-1W%M+3J-\[OE]S^">Y'4
M-5O/UK&Y/'$]E?]$DW>F^"%?,*$)ASE2-H[[6%Y4WNWE$R.7KO^928/=E!LF
MV""#L@=P?RY1SF)B#90M=_ 74$L#!!0 ( ^
AWL6;]!*0, 4^DA]%C+US<32"G5N]O0$5HMZ4D8]Z77:3/H,O">P6N#3
M,O#I:XFIA-:QA(8GY>6TE7)>(RG;%H00>TA*%74>N=0TUSBIDL:4$\:E8W*(.#%#J9(J\F]+TF+M\YS:&F$'9"
M;,;>K[#W.[%_!ECL*#3_T/_]9H*[?L/_!JG ]0,SAT'%8=#9KW3[-X(:7+)!
M7
J50%*I>/;I4XCNTG>QK'MY&BU*D,I7'R[
M